Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Connect Biopharma Holdings Ltd

CNTB
Current price
1.05 USD -0.1 USD (-8.70%)
Last closed 1.15 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 71 042 360 USD
Yield for 12 month +47.47 %
Week
Month
Year
CNTB
21.11.2021 - 28.11.2021

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California. Address: East R&D Building, Taicang, China, 215400

Analytics

WallStreet Target Price

7.05 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -600 856 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -28.95 %
PEG Ratio
Return On Equity TTM -51.52 %
Wall Street Target Price 7.05 USD
Revenue TTM
Book Value 16.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.56 USD
Diluted Eps TTM -1.56 USD
Most Recent Quarter II 2022
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNTB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1891
Price Book MRQ 0.1939

Financials CNTB

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CNTB

For 52 weeks

0.53 USD 2.84 USD
50 Day MA 1.2 USD
Shares Short Prior Month 15 565
200 Day MA 1.09 USD
Short Ratio 0.32
Shares Short 29 371
Short Percent 0.09 %